Topcon Healthcare introduced InspirePRO while Topcon stock remained delisted
Published on 10/14/2026 at 00:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSProduct launch and ownership status
- Topcon Healthcare introduced InspirePRO on October 9, 2026.
- The wearable perimeter covers glaucoma testing from early defects through advanced disease in one system.
- Topcon Healthcare plans its next ophthalmology event for October 29, 2026 through November 1, 2026.
On October 9, 2026, Topcon Healthcare introduced InspirePRO, a wearable perimeter for visual field testing, while Topcon stock remained delisted after December 2, 2025. GlobeNewswire reported that Topcon Healthcare and RadiusXR presented the device at the American Academy of Ophthalmology annual meeting.
Three dated corporate developments
On October 30, 2025, Topcon disclosed an extraordinary loss and a partial reversal of deferred tax assets in a release on its investor-relations page. On December 1, 2025, the company published a notice regarding the delisting of its shares. Both developments are listed by Topcon in its investor-relations archive.
The latest operating development came on October 9, 2026. Topcon Healthcare introduced InspirePRO with RadiusXR as a strategic partner, giving the group a current product milestone even though the listed-share story ended in 2025.
What does InspirePRO add?
GlobeNewswire said the wearable system provides a full measurement range for visual field testing across the glaucoma continuum, from early detectable defects through advanced disease. The device combines a custom display, eye tracking and clinical software in one portable platform.
That design changes the commercial angle of the announcement. Instead of presenting a single-purpose instrument, Topcon Healthcare is positioning InspirePRO as a system that can support repeated testing across different stages of glaucoma care. The source also described integrated security, interoperability and cloud technology as part of the wider platform.
The next medical date
Topcon Healthcare has scheduled its participation in the 37th Japanese Glaucoma Society meeting and the 80th Japanese Ophthalmological Congress, including a presentation of the GAIA device at the latter event from October 29, 2026 through November 1, 2026, according to NEWSCAST.
Delisting defines the stock status
Topcon's investor-relations page records the December 2, 2025 delisting and directs stakeholders to information on the tender offer and the cash payment connected with the share-consolidation process. For readers tracking Topcon stock, the relevant current development is therefore the healthcare business and its products rather than a listed-market quotation.
Topcon company facts
- Company: Topcon Corporation
- Corporate status: Shares delisted effective December 2, 2025
- Latest product event: InspirePRO introduced on October 9, 2026
